Efficacy in vivo of a cancer therapy strategy combining HSV1716 mediated oncolysis with gene transfer and targeted radiotherapy

摘要: Oncolytic herpes viruses have show promise for the treatment of cancer however it is unlikely that optimal application these will be as single therapeutic agents. An alternative strategy would to utilise deliver transgenes and enhance their tumour cell killing capacity.